Synthetic Biologics, Inc. (SYN)
R&D Expenses
$1.27M
Quarterly · Period ending: · USD
SYN R&D Expenses
Latest reported$1.27Mperiod ending
Latest reported$1.27Mperiod ending
SYN Quarterly R&D Expenses ($570.00K → $1.27M)
Quarterly R&D Expenses
High-resolution chart · PNG
SYN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 1,268,000 | |
| 355,000 | |
| 1,132,000 | |
| 2,551,000 | |
| 1,953,000 | |
| 2,968,000 | |
| 1,915,000 | |
| 2,953,000 | |
| 4,006,000 | |
| 3,133,000 | |
| 2,977,000 | |
| 2,862,000 | |
| 2,570,000 | |
| 3,485,000 | |
| 2,597,000 | |
| 2,779,000 | |
| 1,972,000 | |
| 1,932,000 | |
| 1,118,000 | |
| 979,000 | |
| 914,000 | |
| 1,603,000 | |
| 1,635,000 | |
| 1,927,000 | |
| 4,144,000 | |
| 2,594,000 | |
| 2,418,000 | |
| 2,056,000 | |
| 2,846,000 | |
| 3,572,000 | |
| 3,370,000 | |
| 3,756,000 | |
| 4,137,000 | |
| 4,831,000 | |
| 6,059,000 | |
| 6,729,000 | |
| 7,061,000 | |
| 7,164,000 | |
| 8,155,000 | |
| 8,858,000 | |
| 10,046,000 | |
| 7,508,000 | |
| 6,494,000 | |
| 5,242,000 | |
| 3,693,000 | |
| 2,837,000 | |
| 2,717,000 | |
| 2,711,000 | |
| 1,475,000 | |
| 1,203,000 | |
| 1,118,000 | |
| 10,591,000 | |
| 763,000 | |
| 547,000 | |
| 386,000 | |
| 2,539,077 | |
| 288,964 | |
| 279,641 | |
| 232,318 | |
| 173,627 | |
| 424,573 | |
| 562,478 | |
| 419,213 | |
| -15,205 | |
| 325,662 | |
| 405,645 | |
| 495,994 | |
| 487,315 | |
| 863,272 | |
| 1,168,363 | |
| 2,124,620 | |
| 2,257,944 | |
| 1,573,610 | |
| 1,079,050 | |
| 1,417,123 | |
| 2,334,236 | |
| 0 | |
| 0 | |
| 331,319 | |
| 0 | |
| 0 | |
| -250,250 | |
| 1,622,136 | |
| 0 | |
| 250,250 | |
| 315,405 | |
| 531,104 | |
| 1,622,136 | |
| 1,153,790 | |
| 1,333,512 | |
| 1,686,046 | |
| 1,934,362 | |
| 1,045,773 | |
| 1,070,248 | |
| 892,411 | |
| 882,755 | |
| 902,023 | |
| 1,021,734 | |
| 900,000 | |
| 800,000 |